Clinical Trial Update: Dehydroepiandrosterone (DHEA) and Letrozole in Treating Patients With Metastatic Breast Cancer [Phase 1]

View source ↗

Summary

A Phase 1 trial evaluating the combination of dehydroepiandrosterone (DHEA) and letrozole for metastatic breast cancer was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• DHEA (dehydroepiandrosterone)
• Letrozole (letrozole)

Snippet

Sponsor: OHSU Knight Cancer Institute | Conditions: Breast Cancer | Phase 1 | Status: TERMINATED